NanoVibronix, Inc. (NASDAQ:NAOV – Get Free Report) crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.95 and traded as low as $0.75. NanoVibronix shares last traded at $0.80, with a volume of 33,459 shares changing hands.
NanoVibronix Stock Performance
The business’s fifty day moving average is $0.95 and its 200-day moving average is $1.02. The firm has a market cap of $2.23 million, a P/E ratio of -0.38 and a beta of 1.25.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in the business. Geode Capital Management LLC raised its holdings in NanoVibronix by 5.5% in the 4th quarter. Geode Capital Management LLC now owns 218,442 shares of the company’s stock valued at $54,000 after buying an additional 11,344 shares during the last quarter. Vanguard Group Inc. raised its holdings in NanoVibronix by 68.2% during the 3rd quarter. Vanguard Group Inc. now owns 28,416 shares of the company’s stock worth $56,000 after purchasing an additional 11,517 shares during the last quarter. Armistice Capital LLC bought a new position in NanoVibronix during the 3rd quarter worth approximately $57,000. Finally, State Street Corp raised its holdings in NanoVibronix by 32.1% during the 1st quarter. State Street Corp now owns 125,390 shares of the company’s stock worth $145,000 after purchasing an additional 30,500 shares during the last quarter. Institutional investors own 16.39% of the company’s stock.
About NanoVibronix
NanoVibronix, Inc, through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use.
Featured Stories
- Five stocks we like better than NanoVibronix
- P/E Ratio Calculation: How to Assess Stocks
- Comprehensive Analysis of PayPal Stock
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Intuitive Surgical Stock Can Trend Much Higher This YearÂ
- Overbought Stocks Explained: Should You Trade Them?
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Receive News & Ratings for NanoVibronix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoVibronix and related companies with MarketBeat.com's FREE daily email newsletter.
